GlassScriptPhysician profile
Brenda J Hott
NPI 1649221821
$8,249.73
in general payments reported to CMS, 2019-2025
34 companies · $1,054 in 2025
The $1,054 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $1,169 · 2021: $583 · 2022: $1,046 · 2023: $1,342 · 2024: $2,911 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,307.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,240.29 | 2020-2025 | Farxiga, Brilinta, Lokelma |
| Cvrx, INC. | $919.62 | 2019-2025 | Barostim Neo System |
| Abbott Laboratories | $861.65 | 2020-2024 | Mitraclip |
| Abiomed | $608.34 | 2022-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $566.80 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.82 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $331.00 | 2022-2025 | Avvigo Guidance System, Watchman Flx, Watchman |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $304.05 | 2020-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $296.89 | 2022-2025 | Camzyos |
| Ancora Heart, INC. | $238.01 | 2024 | Accucinch |
| Biotronik INC. | $229.00 | 2022-2023 | Acticor 7 Vr-T Dx |
| Amgen INC. | $227.93 | 2019-2024 | Repatha |
| Esperion Therapeutics, INC. | $198.92 | 2021-2025 | Nexletol |
| Impulse Dynamics (USA) INC. | $198.63 | 2024 | Optimizer |
| G Medical Diagnostic Services, INC. | $173.94 | 2024 | Cardiac Monitoring Suite |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $168.98 | 2021-2024 | |
| Medtronic, INC. | $147.96 | 2021-2025 | Micra |
| Kestra Medical Technology Services, INC. | $147.04 | 2023-2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $140.70 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $138.33 | 2020 | |
| Nuwellis, INC. | $130.16 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.49 | 2025 | |
| Edwards Lifesciences Corporation | $72.91 | 2020-2024 | Hemosphere, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Daiichi Sankyo INC. | $69.59 | 2022-2023 | Injectafer |
| Heartflow, INC. | $66.93 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $64.14 | 2025 | Amvuttra |
| Merck Sharp & Dohme LLC | $49.96 | 2021-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $38.45 | 2021 | |
| Philips North America LLC | $38.25 | 2025 | Ecc Solutions |
| Scpharmaceuticals INC. | $32.96 | 2024-2025 | |
| Novo Nordisk INC | $20.38 | 2024 | Rybelsus, Ozempic |
| Lexicon Pharmaceuticals, INC. | $18.20 | 2024 | |
| Sanofi-Aventis U.S. LLC | $17.44 | 2019 | |
| Amarin Pharma, INC. | $15.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Hott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.